In 2016 alone, the total U.S. clinical and diagnostic laboratory market generated approximately $80 billion in revenue, according to industry U.S. Securities and Exchange Commission filings. Just six years earlier in 2010, that market generated $55 billion in revenues. In light of the progressively aging population, as well as the ever-increasing influence of lab testing on clinical decision-making, there is no reason why the present growth in the market for laboratory services should plateau in the near future, and the laboratory market remains ripe for opportunity. …

To continue reading this Law360 column, co-written with my colleagues Paul Kiehl and Bart Walker, click here.